FDA approves SORILUX(R) for Adolescent Plaque Psoriasis

Mayne Pharma Group Limited has announced that the US Food and Drug Administration (FDA) has approved SORILUX® (...

May 23, 2019 | Thursday | News
Sandoz receives regulatory approval from NMPA for Rosuvastatin

Sandoz has announced that it has received regulatory approval from China's National Medical Products Administration (NMP...

May 9, 2019 | Thursday | News
Alembic set to sell its drugs into Chinese market

Alembic has entered into a Joint Venture Agreement ('JVA') with SPH SINE Pharmaceutical Laboratories Co Ltd, China ('SPH...

May 8, 2019 | Wednesday | News
CStone, Numab enter into an exclusive licensing agreement for ND021

CStone Pharmaceuticals and Numab Therapeutics AG have entered into an exclusive regional licensing agreement for the dev...

May 2, 2019 | Thursday | News
EirGenix inks commercialization agreement with Sandoz

EirGenix, Inc. has entered into a license agreement with global generic and biosimilar drug manufacturer Sandoz AG, gran...

April 30, 2019 | Tuesday | News
Teva launches generic AndroGel

Teva Pharmaceutical Industries Ltd. announced the launch of a generic version of AndroGel ®i (testosterone...

April 22, 2019 | Monday | News
Teva announces launch of generic version of EXJADE®

Teva Pharmaceutical has announced the launch of a generic version of EXJADE®1 (deferasirox) Tablets for Oral Su...

March 25, 2019 | Monday | News
FDA accepts NDA for Lemborexant to treat Insomnia

Eisai Co., Ltd. and Imbrium Therapeutics L.P., a clinical-stage biopharmaceutical company and operating subsidiary of Pu...

March 12, 2019 | Tuesday | News
Vitruvias, Sinotherapeutics launch approved version of Propafenone ER in the U.S.

Vitruvias Therapeutics Inc., an Auburn, Alabama-based finished-dose generic drug company, and Sinotherapeutics Inc., a S...

March 11, 2019 | Monday | News
CHMP backs Sanofi's Dupixen in asthma

Regeneron Pharmaceuticals and Sanofi recently announced that the European Medicines Agency's Committee fo...

March 8, 2019 | Friday | News
Lupin receives FDA approval for generic version Vidaza

Pharma major Lupin announced that it has received approval for its Azacitidine for Injection, 100 mg Single-Dose Vial fr...

March 1, 2019 | Friday | News
Novartis receives FDA approval for Egaten

Novartis has announced that the US Food and Drug Administration (FDA) approval of Egaten (triclabendazole) for the treat...

February 20, 2019 | Wednesday | News
Lupin launches Tadalafil Tablets

Pharma major Lupin announced the launch of Tadalafil Tablets USP 20mg, having received an approval from the United State...

February 13, 2019 | Wednesday | News
Lupin receives FDA approval for Fluoxetine Tablets

Pharma major Lupin announced that it has received approval for its Fluoxetine Tablets USP, 60mg, from the United States ...

February 13, 2019 | Wednesday | News
Lupin announces launch of NaMuscla

India based pharma company Lupin has announced the launch of NaMuscla® (mexiletine) in Germany and the United Kingdo...

February 4, 2019 | Monday | News
Mylan's generic version of ADVAIR DISKUS for asthma, COPD patients gets FDA approval

Mylan has announced the U.S. Food and Drug Administration approval of Wixela Inhub (fluticasone propionate and salmetero...

February 1, 2019 | Friday | News
Cipla receives approval for Pfizer’s Depo-Provera

Global pharma company, Cipla has announced that it has received final approval for its Abbreviated New Drug Application ...

January 28, 2019 | Monday | News
Glenmark receives tentative ANDA approval for Topiramate

Glenmark Pharmaceuticals Inc., has been granted tentative approval by the United States Food & Drug Administration (...

January 24, 2019 | Thursday | News